ArticleJournal of bioethical inquiry2013
Personalised medicine: a critique on the future of health care.
Article in Journal of bioethical inquiry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Machine learning prediction of mortality in pediatric fungemia using the Candida score.Scientific reports · 2025Article
- The ethical aspects of human organ-on-chip models: A mapping review.Stem cell reports · 2025Review
- Forgetting how we ate: personalised nutrition and the strategic uses of history.History and philosophy of the life sciences · 2024Article
- Ethical implications of epigenetics in the era of personalized medicine.Clinical epigenetics · 2022Review
- Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?Health care analysis : HCA : journal of health philosophy and policy · 2019Article
- Precision public health-the Emperor's new clothes.International journal of epidemiology · 2019Article
- Precision in health care.Medicine, health care, and philosophy · 2018Article
- Risks of nutrigenomics and nutrigenetics? What the scientists say.Genes & nutrition · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years we have seen the emergence of "personalised medicine." This development can be seen as the logical product of reductionism in medical science in which disease is increasingly understood in molecular terms. Personalised medicine has flourished as a consequence of the application of neoliberal principles to health care, whereby a commercial and social need for personalised medicine has been created. More specifically, personalised medicine benefits from the ongoing commercialisation of the body and of genetic knowledge, the idea that health is defined by genetics, and the emphasis the state places on individual citizens as being "responsible for" their own health. In this paper I critique the emergence of personalised medicine by examining the ways in which it has already impacted upon health and health care delivery.
Indexed as
Identifiers
23515958What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.